The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system
- PMID: 25824528
- DOI: 10.1111/jnc.13109
The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system
Abstract
GPR37 is an orphan G protein-coupled receptor mostly enriched in brain areas such as the cerebellum, striatum, and hippocampus. Identified as a substrate of parkin, GPR37 has been suggested to play a role in Parkinson's disease. Distributed throughout the brain, the function of GPR37, however, remains unknown. We now provide the first mapping of GPR37 within the hippocampus, where GPR37 is widely expressed and localized at the level of the extrasynaptic plasma membrane of dendritic spines, dendritic shafts, and axon terminals. GPR37 per se does not appear to play a role in learning and memory, since knocking out GPR37 (GPR37-KO) did not alter the performance in different hippocampal-related memory tasks. This is in agreement with slice electrophysiology experiments showing no differences both in short-term plasticity paired-pulse facilitation and long-term potentiation between WT and GPR37-KO mice. However, we report a potential functional interaction between GPR37 and adenosine A2A receptors (A2 A R) in the hippocampus, with A2 A R modulating the GPR37-associated phenotype. Thus, the absence of GPR37 appeared to sensitize mice to hippocampal A2 A R-mediated signaling, as observed by the effect of the A2 A R antagonist SCH58261 increasing synaptic depotentiation, reducing novel object recognition memory and reverting the anxiolytic effect of GPR37 deletion. Collectively, these findings afford insight into the localization and role of the orphan GPR37 within the hippocampus with potential involvement in A2 A R function (i.e., A2 A R sensitization). GPR37 is an orphan G protein-coupled receptor widely expressed in the hippocampus and localized at the level of the extrasynaptic plasma membrane of dendritic spines, dendritic shafts and axon terminals. This orphan receptor per se does not appear to directly control the learning and memory processes; however knocking-out GPR37 triggers anxiolytic-like effects and sensitizes mice to hippocampal A2A R-mediated signalling.
Keywords: GPR37; adenosine A2A receptor; hippocampus; synaptic plasticity.
© 2015 International Society for Neurochemistry.
Similar articles
-
Chronic adenosine A2A receptor blockade induces locomotor sensitization and potentiates striatal LTD IN GPR37-deficient mice.J Neurochem. 2019 Mar;148(6):796-809. doi: 10.1111/jnc.14653. Epub 2019 Jan 28. J Neurochem. 2019. PMID: 30578680
-
Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.Behav Brain Res. 2015 Jul 15;288:103-6. doi: 10.1016/j.bbr.2015.04.001. Epub 2015 Apr 9. Behav Brain Res. 2015. PMID: 25862943
-
Mice lacking the Parkinson's related GPR37/PAEL receptor show non-motor behavioral phenotypes: age and gender effect.Genes Brain Behav. 2013 Jun;12(4):465-77. doi: 10.1111/gbb.12041. Epub 2013 May 6. Genes Brain Behav. 2013. PMID: 23574697
-
Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1.Front Pharmacol. 2015 Nov 17;6:275. doi: 10.3389/fphar.2015.00275. eCollection 2015. Front Pharmacol. 2015. PMID: 26635605 Free PMC article. Review.
-
Targeting adenosine A2A receptors in Parkinson's disease.Trends Neurosci. 2006 Nov;29(11):647-54. doi: 10.1016/j.tins.2006.09.004. Epub 2006 Oct 9. Trends Neurosci. 2006. PMID: 17030429 Review.
Cited by
-
Impact of miR-29c-3p in the Nucleus Accumbens on Methamphetamine-Induced Behavioral Sensitization and Neuroplasticity-Related Proteins.Int J Mol Sci. 2024 Jan 11;25(2):942. doi: 10.3390/ijms25020942. Int J Mol Sci. 2024. PMID: 38256016 Free PMC article.
-
Activation of 5-HT1A Receptors Normalizes the Overexpression of Presynaptic 5-HT1A Receptors and Alleviates Diabetic Neuropathic Pain.Int J Mol Sci. 2023 Sep 20;24(18):14334. doi: 10.3390/ijms241814334. Int J Mol Sci. 2023. PMID: 37762636 Free PMC article.
-
Adenosinergic Pathway in Parkinson's Disease: Recent Advances and Therapeutic Perspective.Mol Neurobiol. 2023 Jun;60(6):3054-3070. doi: 10.1007/s12035-023-03257-3. Epub 2023 Feb 14. Mol Neurobiol. 2023. PMID: 36786912 Review.
-
Expression patterns of prosaposin and its receptors, G protein-coupled receptor (GPR) 37 and GPR37L1 mRNAs, in the chick inner ear.Cell Tissue Res. 2023 May;392(2):481-497. doi: 10.1007/s00441-023-03753-x. Epub 2023 Feb 8. Cell Tissue Res. 2023. PMID: 36750499
-
Guanfacine Normalizes the Overexpression of Presynaptic α-2A Adrenoceptor Signaling and Ameliorates Neuropathic Pain in a Chronic Animal Model of Type 1 Diabetes.Pharmaceutics. 2022 Oct 10;14(10):2146. doi: 10.3390/pharmaceutics14102146. Pharmaceutics. 2022. PMID: 36297581 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
